Literature DB >> 26910321

Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.

Alessandro Vanoli1, Stefano La Rosa, Catherine Klersy, Federica Grillo, Luca Albarello, Frediano Inzani, Roberta Maragliano, Rachele Manca, Ombretta Luinetti, Massimo Milione, Claudio Doglioni, Guido Rindi, Carlo Capella, Enrico Solcia.   

Abstract

BACKGROUND: Several types of neuroendocrine neoplasms (NENs) have been described in the duodenal tract, from low-grade tumors (NETs) to high-grade neuroendocrine carcinomas (NECs). A comprehensive analysis of histology, hormonal profile and prognostic parameters of a sufficiently large duodenal NEN series to cover all main kinds of neoplasms is however lacking.
METHODS: We collected a retrospective series of 203 duodenal wall and ampullary region NENs, from six specialized endocrine pathology centers. All were characterized histopathologically and histochemically, and 190 were followed for a median of 9 years.
RESULTS: Twenty-seven poorly differentiated NECs, mostly from the ampullary region, were identified and shown to lead to patient demise in a median of 10 months. Among 176 NETs, four subtypes were characterized, including 20 gastrinomas, 37 ampullary-type somatostatin-producing NETs (ASTs), 12 gangliocytic paragangliomas (GPs) and 106 nonfunctioning NETs (nfNETs). ASTs and GPs were mostly localized in the ampullary/periampullary region, while gastrinomas and nfNETs were mainly from the proximal duodenum. ASTs and gastrinomas showed high rates of local infiltration (especially lymphoinvasion and deep duodenal wall/pancreatic tissue invasion) and lymph node metastasis, while nfNETs had significantly lower and more size-dependent local invasive potential. Disease-specific survival differed significantly between NETs and NECs, though not among NET subtypes. NET cases with distant metastases (n = 23) were significantly associated with larger size, higher proliferative grade, lymphovascular invasion, deep invasion and local lymph node metastasis.
CONCLUSION: Our careful analysis of a large series of duodenal NENs identified five histologically and prognostically different histotypes of potential clinical relevance.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26910321     DOI: 10.1159/000444803

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  31 in total

Review 1.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

2.  Neuroendocrine Carcinoma of Duodenum-an Uncommon Tumour at an Unusual Site.

Authors:  Palki Dewan; Shubha P Bhat; H L Kishan Prasad; Rajesh Ballal; K Sajitha
Journal:  Indian J Surg Oncol       Date:  2018-12-07

Review 3.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

Review 4.  Cyto-histology in NET: what is necessary today and what is the future?

Authors:  Frediano Inzani; Gianluigi Petrone; Guido Fadda; Guido Rindi
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 5.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

6.  Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection.

Authors:  Catherine G Tran; Scott K Sherman; Mohammed O Suraju; Apoorve Nayyar; Henning Gerke; Rami G El Abiad; Chandrikha Chandrasekharan; Po Hien Ear; Thomas M O'Dorisio; Joseph S Dillon; Andrew M Bellizzi; James R Howe
Journal:  Ann Surg Oncol       Date:  2021-09-13       Impact factor: 5.344

Review 7.  Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

Review 8.  Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Andrew M Bellizzi
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

Review 9.  American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.

Authors:  Andrew M Bellizzi; Elizabeth A Montgomery; Jason L Hornick
Journal:  Ann Diagn Pathol       Date:  2019-11-15       Impact factor: 2.090

10.  Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity.

Authors:  A C Milanetto; C Pasquali; M Da Broi; T Brambilla; G Capretti; A Zerbi
Journal:  Langenbecks Arch Surg       Date:  2018-07-24       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.